COLES N ANTHONY
Insider CIK 1197018 · ONXX President & CEO, Director · YMTX Executive Chair, Director · CCG Director · CRSP Director · CERE President and CEO, Director · REGN Director · LH Director · MCK Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2026-01-02 | 2026-01-06 | 1,962 | — | $0 | 1,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 155 | — | $0 | 1,714 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-01-02 | 2025-01-06 | 1,958 | — | $0 | 1,958 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 166 | — | $0 | 1,559 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 46,322 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 4,809,418 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 15,638 | — | $0 | 10,290 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 10,290 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-07-01 | 2024-07-03 | 25,000 | — | $0 | 2,177,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-07-01 | 2024-07-03 | 25,000 | $41.18 | $1.03M | 25,928 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-07-01 | 2024-07-03 | 25,000 | $3.50 | $87.5K | 50,928 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2024-06-05 | 2024-06-07 | 10,290 | — | $0 | 25,928 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-06-03 | 2024-06-05 | 50,000 | — | $0 | 2,202,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-06-03 | 2024-06-05 | 50,000 | $3.50 | $175.0K | 65,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-06-03 | 2024-06-05 | 50,000 | $40.61 | $2.03M | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-05-10 | 2024-05-14 | 50,000 | — | $0 | 2,252,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-05-10 | 2024-05-14 | 50,000 | $3.50 | $175.0K | 65,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-05-10 | 2024-05-14 | 50,000 | $42.10 | $2.10M | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-04-01 | 2024-04-03 | 50,000 | — | $0 | 2,302,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-04-01 | 2024-04-03 | 50,000 | $3.50 | $175.0K | 65,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-04-01 | 2024-04-03 | 50,000 | $42.33 | $2.12M | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-03-04 | 2024-03-06 | 50,000 | — | $0 | 2,352,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-03-04 | 2024-03-06 | 50,000 | $41.01 | $2.05M | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-03-04 | 2024-03-06 | 50,000 | $3.50 | $175.0K | 65,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-02-29 | 2024-03-04 | 50,000 | — | $0 | 2,402,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-02-29 | 2024-03-04 | 50,000 | $41.16 | $2.06M | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-02-29 | 2024-03-04 | 50,000 | $3.50 | $175.0K | 65,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-02-07 | 2024-02-08 | 2,506 | $41.54 | $104.1K | 15,638 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-02-06 | 2024-02-08 | 15,440 | — | $0 | 46,322 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-02-06 | 2024-02-08 | 15,440 | — | $0 | 18,144 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-01-02 | 2024-01-04 | 1,607 | — | $0 | 1,607 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2024-01-02 | 2024-01-04 | 50,000 | — | $0 | 2,452,417 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 135 | — | $0 | 1,393 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2024-01-02 | 2024-01-04 | 50,000 | $42.24 | $2.11M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2024-01-02 | 2024-01-04 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-14 | 2023-11-16 | 22,824 | — | $0 | 2,502,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-14 | 2023-11-16 | 22,824 | $25.13 | $573.6K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-14 | 2023-11-16 | 22,824 | $3.50 | $79.9K | 25,528 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-08 | 2023-11-09 | 100 | — | $0 | 2,525,241 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-08 | 2023-11-09 | 100 | $3.50 | $350 | 2,804 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-08 | 2023-11-09 | 100 | $25.16 | $2.5K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-07 | 2023-11-09 | 27,076 | — | $0 | 2,525,341 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-07 | 2023-11-09 | 27,076 | $3.50 | $94.8K | 29,780 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-07 | 2023-11-09 | 27,076 | $25.02 | $677.4K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-03 | 2023-11-06 | 61,401 | — | $0 | 2,552,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-03 | 2023-11-06 | 61,401 | $3.50 | $214.9K | 64,105 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-03 | 2023-11-06 | 61,401 | $25.43 | $1.56M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-02 | 2023-11-06 | 38,599 | — | $0 | 2,613,818 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-02 | 2023-11-06 | 38,599 | $25.19 | $972.3K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-02 | 2023-11-06 | 38,599 | $3.50 | $135.1K | 41,303 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-09-07 | 2023-09-08 | 50,000 | — | $0 | 2,652,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-09-07 | 2023-09-08 | 50,000 | $24.07 | $1.20M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-09-07 | 2023-09-08 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-07-11 | 2023-07-13 | 50,000 | — | $0 | 2,702,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-07-11 | 2023-07-13 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-07-11 | 2023-07-13 | 50,000 | $30.03 | $1.50M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-06-01 | 2023-06-05 | 50,000 | — | $0 | 2,752,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-06-01 | 2023-06-05 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-06-01 | 2023-06-05 | 50,000 | $32.60 | $1.63M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-05-04 | 2023-05-08 | 50,000 | — | $0 | 2,802,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-05-04 | 2023-05-08 | 300 | $32.93 | $9.9K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-05-04 | 2023-05-08 | 12,132 | $31.76 | $385.3K | 3,004 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-05-04 | 2023-05-08 | 37,568 | $31.36 | $1.18M | 15,136 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-05-04 | 2023-05-08 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-04-11 | 2023-04-13 | 50,000 | — | $0 | 2,852,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-04-11 | 2023-04-13 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-04-11 | 2023-04-13 | 50,000 | $25.06 | $1.25M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-03-03 | 2023-03-06 | 3,000 | — | $0 | 2,902,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-03-03 | 2023-03-06 | 3,000 | $27.19 | $81.6K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-03-03 | 2023-03-06 | 3,000 | $3.50 | $10.5K | 5,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-03-02 | 2023-03-06 | 47,000 | — | $0 | 2,905,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-03-02 | 2023-03-06 | 47,000 | $27.11 | $1.27M | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-03-02 | 2023-03-06 | 47,000 | $3.50 | $164.5K | 49,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-02-07 | 2023-02-08 | 50,000 | — | $0 | 2,952,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-02-07 | 2023-02-08 | 7,942 | $33.57 | $266.6K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-02-07 | 2023-02-08 | 42,058 | $33.04 | $1.39M | 10,646 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-02-07 | 2023-02-08 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 243,042 | — | $0 | 243,042 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 61,762 | — | $0 | 61,762 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-01-05 | 2023-01-06 | 50,000 | — | $0 | 3,002,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-01-05 | 2023-01-06 | 500 | $30.73 | $15.4K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-01-05 | 2023-01-06 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-01-05 | 2023-01-06 | 49,500 | $29.93 | $1.48M | 3,204 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 1,258 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-12-28 | 2022-12-30 | 2,145 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-12-28 | 2022-12-30 | 3,613 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 2,266 | $715.48 | $1.62M | 1,404 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 1,022 | $714.61 | $730.3K | 3,670 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 1,198 | $713.66 | $855.0K | 4,692 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 100 | $711.95 | $71.2K | 5,890 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 679 | $710.63 | $482.5K | 5,990 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 1 | $709.92 | $710 | 6,669 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 311 | $716.08 | $222.7K | 1,093 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-12-28 | 2022-12-30 | 3,613 | $482.68 | $1.74M | 6,851 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-12-28 | 2022-12-30 | 2,145 | $374.12 | $802.5K | 3,238 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-12-28 | 2022-12-30 | 181 | $707.87 | $128.1K | 6,670 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-12-09 | 2022-12-13 | 50,000 | — | $0 | 3,052,417 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-12-09 | 2022-12-13 | 5,145 | $27.09 | $139.4K | 2,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-12-09 | 2022-12-13 | 50,000 | $3.50 | $175.0K | 52,704 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-12-09 | 2022-12-13 | 44,855 | $26.62 | $1.19M | 7,849 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-06 | 2022-09-08 | 2,216 | — | $0 | 2,145 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-06 | 2022-09-08 | 3,784 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 550 | $579.85 | $318.9K | 5,470 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 273 | $578.25 | $157.9K | 6,020 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 500 | $577.07 | $288.5K | 6,293 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-06 | 2022-09-08 | 3,784 | $371.40 | $1.41M | 6,793 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 300 | $576.73 | $173.0K | 3,009 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-06 | 2022-09-08 | 2,216 | $374.12 | $829.0K | 3,309 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 688 | $580.44 | $399.3K | 4,782 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 1,220 | $582.56 | $710.7K | 2,740 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 1,045 | $583.16 | $609.4K | 1,695 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 822 | $581.44 | $477.9K | 3,960 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-06 | 2022-09-08 | 602 | $584.57 | $351.9K | 1,093 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 425,772 | — | $0 | 425,772 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-01-03 | 2022-01-05 | 2,707 | — | $0 | 2,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 191 | — | $0 | 1,093 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-15 | 2021-09-17 | 5,039 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-15 | 2021-09-17 | 6,909 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 3 | $662.55 | $2.0K | 2,981 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 3,344 | $661.56 | $2.21M | 2,984 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 448 | $660.78 | $296.0K | 6,328 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 300 | $659.00 | $197.7K | 6,776 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 935 | $658.65 | $615.8K | 7,076 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 835 | $657.53 | $549.0K | 8,011 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 1,400 | $656.48 | $919.1K | 8,846 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 403 | $655.14 | $264.0K | 10,246 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 800 | $653.31 | $522.6K | 10,649 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 1,101 | $652.95 | $718.9K | 11,449 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 300 | $651.36 | $195.4K | 12,550 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-15 | 2021-09-17 | 5,039 | $345.47 | $1.74M | 12,850 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 905 | $663.73 | $600.7K | 2,076 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-15 | 2021-09-17 | 1,174 | $664.32 | $779.9K | 902 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-15 | 2021-09-17 | 6,909 | $380.95 | $2.63M | 7,811 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-18 | 2021-08-19 | 5,100 | — | $0 | 5,039 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-18 | 2021-08-19 | 5,100 | $650.00 | $3.31M | 902 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-18 | 2021-08-19 | 5,100 | $345.47 | $1.76M | 6,002 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-17 | 2021-08-19 | 900 | — | $0 | 10,139 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-17 | 2021-08-19 | 900 | $650.00 | $585.0K | 902 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-17 | 2021-08-19 | 900 | $345.47 | $310.9K | 1,802 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-13 | 2021-08-16 | 2,000 | — | $0 | 11,039 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-13 | 2021-08-16 | 2,000 | $345.47 | $690.9K | 2,902 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-13 | 2021-08-16 | 2,000 | $625.00 | $1.25M | 902 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-04-01 | 2021-04-02 | 78,650 | — | $0 | 78,650 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-02-03 | 2021-02-05 | 732,714 | — | $0 | 732,714 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2021-02-01 | 2021-02-03 | 1,118 | — | $0 | 691,008 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 3,613 | — | $0 | 3,613 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-01-04 | 2021-01-05 | 248 | — | $0 | 902 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 72,496 | — | $0 | 72,496 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 12,082 | — | $0 | 12,082 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 6,038 | — | $0 | 6,038 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2020-12-22 | 2020-12-28 | 689,890 | — | $0 | 689,890 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2020-12-22 | 2020-12-28 | 52,669 | — | $0 | 52,669 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-11-13 | 2020-11-13 | 11 | — | $0 | 13,039 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-11-13 | 2020-11-13 | 11 | $345.47 | $3.8K | 654 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2020-10-28 | 2020-10-30 | 196,335 | — | $0 | 196,335 | SEC↗ |
| MCK MCKESSON CORP | S Sale | 2020-08-17 | 2020-08-19 | 2,453 | $156.77 | $384.6K | 0 | SEC↗ |
| MCK MCKESSON CORP | A Award | 2020-07-29 | 2020-07-31 | 1,157 | — | $0 | 2,453 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-01-02 | 2020-01-06 | 4,361 | — | $0 | 4,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-01-02 | 2020-01-06 | 320 | — | $0 | 643 | SEC↗ |
| MCK MCKESSON CORP | A Award | 2019-07-31 | 2019-08-01 | 1,296 | — | $0 | 1,296 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-04 | 3,784 | — | $0 | 3,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-04 | 323 | — | $0 | 323 | SEC↗ |
| MCK MCKESSON CORP | S Sale | 2018-08-31 | 2018-09-04 | 1,350 | $128.69 | $173.7K | 0 | SEC↗ |
| MCK MCKESSON CORP | A Award | 2018-07-25 | 2018-07-26 | 1,350 | — | $0 | 1,350 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-04 | 6,909 | — | $0 | 6,909 | SEC↗ |
| MCK MCKESSON CORP | A Award deriv | 2017-07-26 | 2017-07-27 | 1,083 | — | $0 | 1,083 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-27 | 2017-01-31 | 13,050 | — | $0 | 13,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award | 2016-10-24 | 2016-10-26 | 35,000 | $14.00 | $490.0K | 70,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award | 2016-10-24 | 2016-10-26 | 35,000 | $14.00 | $490.0K | 70,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2016-10-18 | 2016-10-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MCK MCKESSON CORP | A Award deriv | 2016-07-27 | 2016-07-28 | 915 | — | $0 | 915 | SEC↗ |
| MCK MCKESSON CORP | A Award deriv | 2015-07-29 | 2015-07-31 | 794 | — | $0 | 794 | SEC↗ |
| MCK MCKESSON CORP | A Award deriv | 2014-07-30 | 2014-07-31 | 785 | — | $0 | 785 | SEC↗ |
| MCK MCKESSON CORP | A Award deriv | 2014-05-15 | 2014-05-16 | 212 | — | $0 | 212 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 2,842 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 139,947 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 2,653 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 45,283 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 75,300 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 143,698 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 3,302 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,247 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | U Tender | 2013-10-01 | 2013-10-03 | 25,632 | $125.00 | $3.20M | 105,566 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2013-10-01 | 2013-10-03 | 105,566 | $125.00 | $13.20M | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-06-05 | 2013-06-07 | 6,562 | — | $0 | 48,125 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-06-05 | 2013-06-07 | 6,562 | $35.18 | $230.9K | 137,760 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-06-05 | 2013-06-07 | 6,562 | $90.00 | $590.6K | 131,198 | SEC↗ |
| CCG Campus Crest Communities, | D To issuer | 2013-04-22 | 2013-05-31 | 16,335 | — | $0 | 3,999 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-03 | 2013-04-03 | 13,776 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-04-03 | 2013-04-03 | 3,502 | — | $0 | 5,247 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-04-03 | 2013-04-03 | 13,776 | $29.03 | $399.9K | 127,696 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-04-03 | 2013-04-03 | 3,502 | $28.55 | $100.0K | 131,198 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-03 | 2013-04-03 | 1,300 | $90.81 | $118.1K | 113,920 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-03 | 2013-04-03 | 8,405 | $89.30 | $750.6K | 115,220 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-01 | 2013-04-03 | 7,859 | $86.14 | $677.0K | 123,625 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-04-01 | 2013-04-03 | 3,770 | $86.14 | $324.7K | 131,484 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2013-03-28 | 2013-04-01 | 10,938 | — | $0 | 54,687 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2013-03-28 | 2013-04-01 | 75,300 | — | $0 | 75,300 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2013-03-28 | 2013-04-01 | 10,938 | $35.18 | $384.8K | 119,392 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2013-03-28 | 2013-04-01 | 26,800 | — | $0 | 135,254 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2013-03-28 | 2013-04-01 | 10,938 | $90.00 | $984.4K | 108,454 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | G Gift | 2013-02-15 | 2013-02-19 | 216 | — | $0 | 2,584 | SEC↗ |
| CCG Campus Crest Communities, | A Award | 2013-01-31 | 2013-01-31 | 7,000 | — | $0 | 20,334 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-10-16 | 2012-10-17 | 86,224 | — | $0 | 13,776 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-10-16 | 2012-10-17 | 39,375 | — | $0 | 65,625 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-10-16 | 2012-10-17 | 39,375 | $35.18 | $1.39M | 233,942 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-10-16 | 2012-10-17 | 125,599 | — | $0 | 108,343 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-10-16 | 2012-10-17 | 86,224 | $29.03 | $2.50M | 194,567 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise deriv | 2012-08-08 | 2012-08-09 | 250,000 | — | $0 | 100,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-08 | 2012-08-09 | 270,690 | $72.18 | $19.54M | 108,343 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-08 | 2012-08-09 | 250,000 | $29.03 | $7.26M | 379,033 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-01 | 2012-08-03 | 8,820 | $74.37 | $655.9K | 154,033 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-07-25 | 2012-07-27 | 11,883 | $73.97 | $879.0K | 162,853 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award | 2012-05-24 | 2012-05-29 | 1,800 | — | $0 | 2,800 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2012-04-02 | 2012-04-03 | 2,406 | $36.58 | $88.0K | 180,104 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2012-04-02 | 2012-04-03 | 3,368 | $36.58 | $123.2K | 176,736 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2012-04-02 | 2012-04-03 | 2,406 | $36.58 | $88.0K | 174,330 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-03-30 | 2012-04-03 | 142,600 | — | $0 | 142,600 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 28,000 | — | $0 | 122,410 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 60,100 | — | $0 | 182,510 | SEC↗ |
| CCG Campus Crest Communities, | A Award | 2012-03-28 | 2012-03-29 | 6,667 | — | $0 | 13,334 | SEC↗ |